Display options
Share it on

Bone Res. 2013 Sep 25;1(3):260-6. doi: 10.4248/BR201303004. eCollection 2013 Sep.

New Clues that May Link Osteoporosis to the Circulating Lipid Profile.

Bone research

Catalina Poiana, Valentin Radoi, Mara Carsote, John P Bilezikian

Affiliations

  1. "C. I. Parhon" National Institute of Endocrinology, Bucharest , Bucharest, Romania ; University of Medicine and Pharmacy "Carol Davila", Bucharest , Bucharest, Romania.
  2. University of Medicine and Pharmacy "Carol Davila", Bucharest , Bucharest, Romania.
  3. College of Physicians and Surgeons, Columbia University , New York, NY USA.

PMID: 26273507 PMCID: PMC4472105 DOI: 10.4248/BR201303004

Abstract

Bone Mineral Density (BMD) is a gold standard for the diagnosis of osteoporosis and is also important in the assessment of fracture risk. Other risk factors have been identified that together make up fracture risk assessment tools such as FRAX. Another potential factor, circulating lipids, has been suggested because of reports linking statins to fracture risk reduction. We analyzed the lipid profile in a cohort of women diagnosed with postmenopausal osteoporosis based on bone density determination: 610 women with osteoporosis (mean lumbar spine T-score -3.16±0.81, mean yrs. since menopause 15.79±8.9) were grouped according to age at evaluation (< 50 years, 51-60 years, 61-70 years, > 70 years), the presence/absence of a history of a fragility fracture, statin and/or antiresorptive drug use. There was no correlation between BMD and Body Mass Index (BMI: P>0.05, r (2)<0.02). However, when BMD was correlated with both BMI and the lipid profile (Triglycerides, Cholesterol, LDLc, HDLc), significant correlations were found in 5 cohorts: 51-60 years with fractures (n=61, r (2)=0.14, P<0.01), 61-70 years (n=201, r (2)=0.09, P<0.01) with fractures (n=88, r (2)=0.14, P<0.01) or without fractures (n=113, r (2)=0.24, P=0.02) and over 70 years (n=247, r (2)=0.11, P<0.01).

Keywords: HDL-cholesterol; bone mineral density; cholesterol; lipid; osteoporosis; triglycerides

References

  1. J Clin Endocrinol Metab. 2001 Sep;86(9):4556-9 - PubMed
  2. Bone. 2012 Feb;50(2):525-33 - PubMed
  3. Curr Pharm Des. 2011 Dec;17(37):4132-46 - PubMed
  4. Eur J Obstet Gynecol Reprod Biol. 2005 May 1;120(1):63-8 - PubMed
  5. Lancet. 2000 Jun 24;355(9222):2185-8 - PubMed
  6. Clin Calcium. 2011 May;21(5):677-82 - PubMed
  7. Nat Rev Endocrinol. 2011 Sep 06;8(2):81-91 - PubMed
  8. Bone. 2003 Jan;32(1):8-14 - PubMed
  9. Bone. 2009 Feb;44(2):208-13 - PubMed
  10. Ann N Y Acad Sci. 2000 Jun;908:244-54 - PubMed
  11. Climacteric. 2011 Feb;14 (1):105-11 - PubMed
  12. Med Hypotheses. 2011 Mar;76(3):317-21 - PubMed
  13. Pharmacotherapy. 2010 Sep;30(9):879-87 - PubMed
  14. Bone. 2003 Apr;32(4):427-33 - PubMed
  15. Ann Intern Med. 2003 Jul 15;139(2):97-104 - PubMed
  16. Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):e6-10 - PubMed
  17. Mol Cell Biochem. 2012 Jan;360(1-2):71-7 - PubMed
  18. Nutr Metab Cardiovasc Dis. 2003 Aug;13(4):227-31 - PubMed
  19. Endocr J. 2008 Mar;55(1):143-51 - PubMed
  20. Science. 1999 Dec 3;286(5446):1946-9 - PubMed
  21. Bone. 2004 Mar;34(3):557-61 - PubMed
  22. Stroke. 1997 Sep;28(9):1730-2 - PubMed
  23. Arch Intern Med. 2004 Jan 26;164(2):146-52 - PubMed
  24. J Bone Miner Res. 2011 Jun;26(6):1197-206 - PubMed
  25. Cleve Clin J Med. 2002 Apr;69(4):277-8, 280-2, 287-8 - PubMed
  26. Metabolism. 2004 Jun;53(6):744-8 - PubMed
  27. Bone. 2010 May;46(5):1226-37 - PubMed
  28. Am J Med. 2005 Dec;118(12):1414 - PubMed
  29. Endocr Res. 2003 Aug;29(3):317-25 - PubMed
  30. Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):133-8 - PubMed
  31. Eur J Epidemiol. 2004;19(12):1105-12 - PubMed
  32. Med Hypotheses. 2006;66(5):960-3 - PubMed

Publication Types